Equity, diversity and inclusion (EDI) is a key element of excellence in research. D2R’s vision is inherently driven by principles of EDI. From its inception, D2R was designed to deliver genomic-based RNA therapies that not only advance scientific discovery but also address the specific needs of medically underserved groups, including those affected by rare and infectious diseases and cancer, and members of equity-deserving groups (EDGs). Moreover, D2R is committed to supporting the recruitment and advancement of RNA researchers from EDGs.
Tools
To support applicants to D2R’s funding opportunities in preparing meaningful EDI sections, the below guidance is offered to researchers.
Events
From educational webinars during Black History Month to expert panels on ethics and equity in RNA science, D2R’s EDI events foster dialogue and inclusive engagement around pressing issues in the field.
